Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab.

Ha, Yeonjung; Kim, Jee Hyun; Cheon, Jaekyung; Jeon, Gyeong Sik; Kim, Chan; Chon, Hong Jae

Ha, Yeonjung; Kim, Jee Hyun; Cheon, Jaekyung; Jeon, Gyeong Sik; Kim, Chan; Chon, Hong Jae.

Afiliação

Ha Y; Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Gyeonggi-do, South Korea.
Kim JH; Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Gyeonggi-do, South Korea.
Cheon J; Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Gyeonggi-do, South Korea.
Jeon GS; Department of Radiology, CHA Bundang Medical Center, CHA University, Gyeonggi-do, South Korea.
Kim C; Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Gyeonggi-do, South Korea. Electronic address: chan@cha.ac.kr.
Chon HJ; Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Gyeonggi-do, South Korea. Electronic address: minidoctor@cha.ac.kr.

Clin Gastroenterol Hepatol ; 21(9): 2421-2423.e2, 2023 08.

Article em En | MEDLINE | ID: mdl-35944830

Assuntos

Carcinoma Hepatocelular; Varizes Esofágicas e Gástricas; Neoplasias Hepáticas; Varizes; Humanos; Bevacizumab/efeitos adversos; Carcinoma Hepatocelular/tratamento farmacológico; Hemorragia Gastrointestinal/induzido quimicamente; Neoplasias Hepáticas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Varizes / Varizes Esofágicas e Gástricas / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google